(202) 599-8435

Third Party Opinion

NY Times Fails To Capture Full Range of Buprenorphine Treatment

In a lengthy front page story, The New York Times recently drew attention to buprenorphine, a medication used to treat addiction to heroin and prescription opioids. As physicians and researchers...
Posted on Nov 22, 2013
, By

Experts Recommend Physician Training in Addiction Medicine

An article for the Journal of the American Medical Association reports that “many in the medical community fail to diagnose and treat substance use disorders, in part because of the failure to...
Posted on Oct 22, 2013
, By

Crushable Opana and OxyContin: A Tough Challenge ahead for Communities and Families

  By Eve Pearce Every day, 100 people in the US die from drug overdoses; most of these are from prescription drugs. The problem has reached such proportions that the FDA recently deemed ...
Posted on Feb 21, 2013
, By

Op-Ed: Congress Should Act To Continue the Manufacture of Tamper-Resistant Pills

If easily abusable opioid formulations are made available again, why should users seeking a high not turn to them? Furthermore, what incentives will spur drug makers to continue to formulate...
Posted on Jan 13, 2013
, By

Generic Pain Relievers Could Undermine Fight Against Abuse

By Brett Norman This article was originally published in POLITICO Pro on December 12, 2012.  It has been reprinted with permission. Some of the most powerful and widely abused painkillers are...
Posted on Dec 12, 2012
, By

Op-Ed: Keep Crushable Pills off the Streets

U.S. Rep. Hal Rogers (KY-05) writes in The Hill’s Congress Blog that allowing non-abuse-deterrent opioids to return to the U.S. market in cheaper, generic form would be “downright disastrous.” If...
Posted on Nov 30, 2012
, By